95 related articles for article (PubMed ID: 15800716)
1. Inoperable oropharyngeal carcinoma treated with concomitant irradiation, mitomycin C and bleomycin - long term results.
Budihna M; Soba E; Smid L; Zakotnik B; Strojan P; Cemazar M; Fajdiga I; Zargi M; Zupevc A; Lesnicar H
Neoplasma; 2005; 52(2):165-74. PubMed ID: 15800716
[TBL] [Abstract][Full Text] [Related]
2. Patterns of failure in patients with locally advanced head and neck cancer treated postoperatively with irradiation or concomitant irradiation with Mitomycin C and Bleomycin.
Zakotnik B; Budihna M; Smid L; Soba E; Strojan P; Fajdiga I; Zargi M; Oblak I; Lesnicar H
Int J Radiat Oncol Biol Phys; 2007 Mar; 67(3):685-90. PubMed ID: 17197122
[TBL] [Abstract][Full Text] [Related]
3. Hemoglobin as a factor influencing the outcome in inoperable oropharyngeal carcinoma treated by concomitant radiochemotherapy.
Oblak I; Strojan P; Zakotnik B; Budihna M; Smid L
Neoplasma; 2003; 50(6):452-8. PubMed ID: 14689069
[TBL] [Abstract][Full Text] [Related]
4. Tumor site predicts outcome after radiochemotherapy in squamous-cell carcinoma of the anal region: long-term results of 101 patients.
Grabenbauer GG; Kessler H; Matzel KE; Sauer R; Hohenberger W; Schneider IH
Dis Colon Rectum; 2005 Sep; 48(9):1742-51. PubMed ID: 15991058
[TBL] [Abstract][Full Text] [Related]
5. Concomitant radiotherapy with mitomycin C and bleomycin compared with radiotherapy alone in inoperable head and neck cancer: final report.
Zakotnik B; Smid L; Budihna M; Lesnicar H; Soba E; Furlan L; Zargi M
Int J Radiat Oncol Biol Phys; 1998 Jul; 41(5):1121-7. PubMed ID: 9719123
[TBL] [Abstract][Full Text] [Related]
6. Intensity-modulated radiation therapy for the treatment of oropharyngeal carcinoma: the Memorial Sloan-Kettering Cancer Center experience.
de Arruda FF; Puri DR; Zhung J; Narayana A; Wolden S; Hunt M; Stambuk H; Pfister D; Kraus D; Shaha A; Shah J; Lee NY
Int J Radiat Oncol Biol Phys; 2006 Feb; 64(2):363-73. PubMed ID: 15925451
[TBL] [Abstract][Full Text] [Related]
7. Analysis of prognostic factors in patients with oropharyngeal squamous cell carcinoma treated with radiotherapy alone or in combination with systemic chemotherapy.
Pedruzzi PA; Kowalski LP; Nishimoto IN; Oliveira BV; Tironi F; Ramos GH
Arch Otolaryngol Head Neck Surg; 2008 Nov; 134(11):1196-204. PubMed ID: 19015451
[TBL] [Abstract][Full Text] [Related]
8. concomitant chemoradiotherapy with mitomycin C and cisplatin in advanced unresectable carcinoma of the head and neck: phase I-II clinical study.
Strojan P; Karner K; Smid L; Soba E; Fajdiga I; Jancar B; Anicin A; Budihna M; Zakotnik B
Int J Radiat Oncol Biol Phys; 2008 Oct; 72(2):365-72. PubMed ID: 18394816
[TBL] [Abstract][Full Text] [Related]
9. Long-term results of hyperfractionated radiation and high-dose intraarterial cisplatin for unresectable oropharyngeal carcinoma.
Spring PM; Valentino J; Arnold SM; Sloan D; Kenady D; Kudrimoti M; Haydon RC; Lee C; Given C; Mohiuddin M; Regine WF
Cancer; 2005 Oct; 104(8):1765-71. PubMed ID: 16149090
[TBL] [Abstract][Full Text] [Related]
10. Prediction of tumor control by tumor regression at 40 Gy/4 weeks of external beam irradiation for oropharyngeal carcinoma.
Ohizumi Y; Tamai Y; Imamiya S; Akiba T
Radiat Med; 2004; 22(5):324-31. PubMed ID: 15553013
[TBL] [Abstract][Full Text] [Related]
11. Neoadjuvant chemotherapy followed by concurrent hyperfractionated radiation therapy and sensitizing chemotherapy for locally advanced (T3-T4) oropharyngeal squamous cell carcinoma.
Finnegan V; Parsons JT; Greene BD; Sharma V
Head Neck; 2009 Feb; 31(2):167-74. PubMed ID: 18853443
[TBL] [Abstract][Full Text] [Related]
12. Intensity-modulated radiation treatment for head-and-neck squamous cell carcinoma--the University of Iowa experience.
Yao M; Dornfeld KJ; Buatti JM; Skwarchuk M; Tan H; Nguyen T; Wacha J; Bayouth JE; Funk GF; Smith RB; Graham SM; Chang K; Hoffman HT
Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):410-21. PubMed ID: 16168834
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of intensified hyperfractionated and accelerated radiotherapy and concurrent chemotherapy with carboplatin and 5-fluorouracil: updated results of a randomized multicentric trial in advanced head-and-neck cancer.
Semrau R; Mueller RP; Stuetzer H; Staar S; Schroeder U; Guntinas-Lichius O; Kocher M; Eich HT; Dietz A; Flentje M; Rudat V; Volling P; Schroeder M; Eckel HE
Int J Radiat Oncol Biol Phys; 2006 Apr; 64(5):1308-16. PubMed ID: 16464538
[TBL] [Abstract][Full Text] [Related]
14. [Radiochemotherapy concepts in advanced carcinomas of the mouth, oro- and hypopharynx].
Schmitt G; Schnabel T
Strahlenther Onkol; 1992 Sep; 168(9):497-501. PubMed ID: 1411922
[TBL] [Abstract][Full Text] [Related]
15. Randomized clinical trial of post-operative radiotherapy versus concomitant carboplatin and radiotherapy for head and neck cancers with lymph node involvement.
Racadot S; Mercier M; Dussart S; Dessard-Diana B; Bensadoun RJ; Martin M; Malaurie E; Favrel V; Housset M; Durdux C; Journel C; Calais G; Huet J; Pillet G; Hennequin C; Haddad E; Diana C; Blaska-Jaulerry B; Henry-Amar M; Géhanno P; Baillet F; Mazeron JJ
Radiother Oncol; 2008 May; 87(2):164-72. PubMed ID: 18222010
[TBL] [Abstract][Full Text] [Related]
16. Results of concomitant chemoradiation for cervical cancer using high dose rate intracavitary brachytherapy: study of JROSG (Japan Radiation Oncology Study Group).
Sakata K; Sakurai H; Suzuki Y; Katoh S; Ohno T; Toita T; Kataoka M; Tanaka E; Kaneyasu Y; Uno T; Harima Y; Nakano T;
Acta Oncol; 2008; 47(3):434-41. PubMed ID: 18348003
[TBL] [Abstract][Full Text] [Related]
17. Hypofractionated radiotherapy denoted as the "Christie scheme": an effective means of palliating patients with head and neck cancers not suitable for curative treatment.
Al-mamgani A; Tans L; Van rooij PH; Noever I; Baatenburg de jong RJ; Levendag PC
Acta Oncol; 2009; 48(4):562-70. PubMed ID: 19373698
[TBL] [Abstract][Full Text] [Related]
18. Preoperative paclitaxel/carboplatin radiochemotherapy for stage III/IV resectable oral and oropharyngeal cancer: seven-year follow-up of a phase II trial.
Eckardt A; Sinikovic B; Hofele C; Bremer M; Reuter C
Oncology; 2007; 73(3-4):198-203. PubMed ID: 18424883
[TBL] [Abstract][Full Text] [Related]
19. Split course hyperfractionated accelerated radio-chemotherapy (SCHARC) for patients with advanced head and neck cancer: influence of protocol deviations and hemoglobin on overall survival, a retrospective analysis.
Stadler P; Putnik K; Kreimeyer T; Sprague LD; Koelbl O; Schäfer C
BMC Cancer; 2006 Dec; 6():279. PubMed ID: 17150114
[TBL] [Abstract][Full Text] [Related]
20. Postoperative concomitant irradiation and chemotherapy with mitomycin C and bleomycin for advanced head-and-neck carcinoma.
Smid L; Budihna M; Zakotnik B; Soba E; Strojan P; Fajdiga I; Zargi M; Oblak I; Dremelj M; LeSnicar H
Int J Radiat Oncol Biol Phys; 2003 Jul; 56(4):1055-62. PubMed ID: 12829141
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
